Skip to main content

Table 2 Combination of DNA methylation from liquid biopsy as Biomarkers for lung cancer diagnosis

From: Methylated DNA/RNA in Body Fluids as Biomarkers for Lung Cancer

DNA methylation combination

Body fluid

Method

Number of cases

Number of controls

Sensitivity%/specificity% or main findings

References

RASSF1A/RARB2

Plasma/csbDNA

qMSP

60

32

87/75

[78]

SHOX2/PTGER4

plasma

Rt-PCR

117

122

67/90 or 90/73

[77]

RTEL1/PCDHGB6

cfDNA

qMSP-PCR

70

80

62.9/90 (AUC0.755)

[17]

HOXD10/PAX9/PTPRN2/STAG3

serum

MSRE/qPCR

23

23

87.8/90.2

[109]

APC/RASSF1A/CDH13/KLK1/DLEC1

plasma

MSP

110

50

83/70

[47]

APC/AIM1/CDH1/DCC/MGMT/RASSF1A

serum

qMSP

76

30

84/57

[79]

DAPK/PAX5b/PAX5a/Dal1/GATA5/SULF2/CXCL14

sputum

MSP

40

90

75/68

[56]

MGMT/DAPK/PAX5β/Dal-1/PCDH20/Jph3/Kif1a

64

64

CSF3R/ERCC1

peripheral leukocyte

pyrosequencing

138

138

Predict higher risk for SCLC

[55]

CDH1/p16/MGMT/DAPK

peripheral lymphocyte

MSP

49

22

methylation of CDH1 and DAPK occurs in the early stages LC

[53]

methylation of p16 and MGMT occurs in later stages LC

p16/RASSF1A/FHIT/RTL

WBC DNA

SYBR Green-based qMSP and qPCR

200

200

AUC 0.670–0.810

[54]

  1. qMSP quantitative methylation-specific PCR, Rt-PCR real-time PCR, MSRE Methylation-Sensitive Restriction Enzymes, qPCR quantitative PCR, csbDNA cell-surface-bound circulating DNA, LC lung cancer, SCLC small cell lung cancer, RASSF1A ras association domain family 1 isoform A, RARβ2 retinoic acid receptor B2, SHOX2 short stature homebox 2, PTGER4 prostaglandin E receptor 4, RTEL1 regulator of telomere elongation helicase 1, PCDHGB6 protocadherin gamma subfamily B, 6, HOXD10 homeobox D10, PAX9 paired box 9, PTPRN2 protein tyrosine phosphatase receptor type N2, STAG3 stromal antigen 3, APC adenomatous polyposis coli, DLEC1 Deleted in lung and esophageal cancer 1, CDH13 cadherin 13, KLK1 kallikrein 1, AIM1 absent in melanoma 1, CDH1 cadherin 1, DCC DCC netrin 1 receptor, MGMT O6 - methylguanine-DNA-methyltransferase, DAPK death-associated protein kinase, PAX5b paired box 5b, PAX5a paired box 5a, GATA5 GATA binding protein 5, SULF2 sulfatase 2, CXCL14 C-X-C motif chemokine ligand 14, PCDH20 protocadherin 20, Jph3 junctophilin 3, CSF3R colony stimulating factor 3 receptor, ERCC1 ERCC excision repair 1, FHIT fragile histidine triad, RTL relative telomere length, p16 cyclin-dependent kinase inhibitor 2A